Human Toll-like receptor 4 recognizes host-specific LPS modifications
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Lipopolysaccharide (LPS) is the principal proinflammatory component of the Gram-negative bacterial envelope and is recognized by the Toll-like receptor 4 (TLR4)-MD-2 receptor complex. Bacteria can alter the acylation state of their LPS in response to environmental changes. One opportunistic bacterium, Pseudomonas aeruginosa, synthesizes more highly acylated (hexa-acylated) LPS structures during adaptation to the cystic fibrosis airway. Here we show that human, but not murine, TLR4-MD-2 recognizes this adaptation and transmits robust proinflammatory signals in response to hexa-acylated but not penta-acylated LPS from P. aeruginosa. Whereas responses to lipidIVA and taxol are dependent on murine MD-2, discrimination of P. aeruginosa LPS structures is mediated by an 82-amino-acid region of human TLR4 that is hypervariable across species. Thus, in contrast to mice, humans use TLR4 to recognize a molecular signature of bacterial-host adaptation to modulate the innate immune response.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, hexa-acylated LPS potently activates TLR4 and host immunity, whereas hypo-acylated penta- and tetra-acylated LPS poorly activate TLR4 and can antagonize immune activation by hexa-acylated LPS6–9.”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“although the LPS response between human and mouse TLR4/MD2 has been shown to differ8”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“The ability of human TLR4/MD2 to discriminate LPS of distinct acylation states differs from that of mouse TLR4/MD28”
From Gut microbiota-derived hexa-acylated lipopolysaccharides enhance cancer immunotherapy responses (2025) · cites this paper as [8]
In the citing paper
“Endotoxin causes inflammatory activation mainly via activating TLR4 (with co-receptor MD2) on the cell surface, resulting in NF-κB transcriptional activation of hundreds of inflammatory genes, including pro-inflammatory cytokines such as TNFα, IL-6 and pro-IL-1β [4, 17, 18].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [4]
In the citing paper
“LPS toxicity varies depending on lipid A composition, and this depends on bacterial species, strain and environmental conditions [3–5].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [4]
Citations
Cites
The Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., Huffel, C. V., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., et al. (1998) · Science · doi:10.1126/science.282.5396.2085 · Cited by 7,631
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80119-3 · Cited by 3,362
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,185
TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., & Schwartz, D. A. (2000) · Nature Genetics · doi:10.1038/76048 · Cited by 2,024
Rozas, J., & Rozas, R. (1999) · Bioinformatics · doi:10.1093/bioinformatics/15.2.174 · Cited by 1,968
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
Qureshi, S. T., Larivière, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., & Malo, D. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.615 · Cited by 1,525
Receptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“; and CD14, which is a high-affinity glycosyl-phosphatidyl inositol–linked LPS-binding protei”
BackgroundThe Pfam Protein Families Database
Bateman, A. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.263 · Cited by 1,256
Hirschfeld, M., Ma, Y., Weis, J. H., Vogel, S. N., & Weis, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.618 · Cited by 1,153
Davis, P. B., Drumm, M., & Konstan, M. W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912731 · Cited by 764
Tlr4: central component of the sole mammalian LPS sensor
Beutler, B. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00046-1 · Cited by 762
Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide
Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K., Fenton, M. J., Oikawa, M., Qureshi, N., Monks, B., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8541 · Cited by 727
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Self-citationLipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Self-citationLipopolysaccharide Is in Close Proximity to Each of the Proteins in Its Membrane Receptor Complex
da Silva Correia, J., Soldau, K., Christen, U., Tobias, P. S., & Ulevitch, R. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009164200 · Cited by 649
Regulation of Lipid A Modifications by Salmonella typhimurium Virulence Genes phoP-phoQ
Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., & Miller, S. I. (1997) · Science · doi:10.1126/science.276.5310.250 · Cited by 559
Self-citationLongitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I. (1999) · Science · doi:10.1126/science.286.5444.1561 · Cited by 484
Self-citationHajjar, A. M., O’Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., & Wilson, C. B. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.15 · Cited by 465
Self-citationAkashi, S., Shimazu, R., Ogata, H., Nagai, Y., Takeda, K., Kimoto, M., & Miyake, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.7.3471 · Cited by 460
Role of CFTR in Airway Disease
PILEWSKI, J. M., & FRIZZELL, R. A. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s215 · Cited by 447
Poltorak, A., Ricciardi-Castagnoli, P., Citterio, S., & Beutler, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040565397 · Cited by 429
Pathophysiology of Gene-Targeted Mouse Models for Cystic Fibrosis
GRUBB, B. R., & BOUCHER, R. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.s193 · Cited by 410
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Self-citationSupajatura, V., Ushio, H., Nakao, A., Okumura, K., Ra, C., & Ogawa, H. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.2250 · Cited by 370
Kawasaki, K., Akashi, S., Shimazu, R., Yoshida, T., Miyake, K., & Nishijima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2251 · Cited by 355
Genetic control of susceptibility to Salmonella typhimurium in mice: role of the LPS gene.
O'Brien, A. D., Rosenstreich, D. L., Scher, I., Campbell, G. H., MacDermott, R. P., & Formal, S. B. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.124.1.20 · Cited by 354
A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.
Somerville, J. E., Cassiano, L., Bainbridge, B., Cunningham, M. D., & Darveau, R. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118423 · Cited by 275
Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition
Akashi, S., Nagai, Y., Ogata, H., Oikawa, M., Fukase, K., Kusumoto, S., Kawasaki, K., Nishijima, M., Hayashi, S., Kimoto, M., et al. (2001) · International Immunology · doi:10.1093/intimm/13.12.1595 · Cited by 245
Visintin, A., Mazzoni, A., Spitzer, J. A., & Segal, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211445098 · Cited by 230
The innate immune system in cystic fibrosis lung disease
Bals, R., Weiner, D. J., & Wilson, J. M. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6277 · Cited by 213
Walker, K., & Croteau, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250491997 · Cited by 186
Cystic Fibrosis and the Salt Controversy
Guggino, W. B. (1999) · Cell · doi:10.1016/s0092-8674(00)80570-x · Cited by 137
Cystic fibrosis salt/fluid controversy: In the thick of it
Guggino, W. B. (2001) · Nature Medicine · doi:10.1038/90914 · Cited by 28
Research works printed but not linked: 1
- Raetz, C. R. H. Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, in Escherichia coli and Salmonella (ed. Neidhardt, F. C.) 1035–1063 (ASM, Washington DC, 1996).
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
Animal models of acute lung injury
Matute-Bello, G., Frevert, C. W., & Martin, T. R. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00010.2008 · Cited by 1,728
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling
Ciesielska, A., Matyjek, M., & Kwiatkowska, K. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03656-y · Cited by 1,420
Metadata
- Authors
- Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I.
- Affiliations
- University of Washington (US)
- Corresponding author
- Wilson, Christopher B.
- Miller, Samuel I.
- Venue
- Nature Immunology
- Published
- 2002-03-25
- Volume
- 3
- Issue
- 4
- Pages
- 354-359
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2078895028
- Cited by
- 579
- References
- 36
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 8 · 2023: 19 · 2022: 20 · 2021: 25 · 2020: 19 · 2019: 15 · 2018: 20 · 2017: 19 · 2016: 23 · 2015: 17 · 2014: 38 · 2013: 27 · 2012: 21
- FWCI
- 11.38
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cystic Fibrosis Foundation
- National Heart, Lung, and Blood Institute (R01HL069503, R01HL065898, HL65898, HL 69503)
- National Institute of Allergy and Infectious Diseases (AI 47938, R01AI047938)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- TLR4, lipopolysaccharide, Pseudomonas aeruginosa, MD-2, cystic fibrosis, innate immunity, host adaptation, lipid A, paclitaxel, hypervariable region, host-bacteria interactions
- MeSH terms
- Animals, Antigens, Surface, Binding Sites, Carbohydrate Sequence, Cell Differentiation, Cell Line, Humans, Infant, Lipid A, Membrane Glycoproteins, Molecular Sequence Data, Pseudomonas aeruginosa, Receptors, Cell Surface, Drosophila Proteins, Toll-Like Receptors, Toll-Like Receptor 4, Lymphocyte Antigen 96, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.